This Co-op intern role within the Global Engineering organization focuses on supporting the Electronic Batch Record (EBR) system. The individual will be involved in designing, authoring, documenting, and testing MES (Manufacturing Execution System) EBRs for drug product manufacturing processes, translating process requirements into practical electronic batch records, and gaining exposure to MES and manufacturing processes.
Perform MES recipe design and authoring following best practices and impact assessment.,Support configuration of master data in the system.,Directly support operations with EBR execution, troubleshooting, and issue resolution for MES and automation systems.,Participate in validation activities in conjunction with IT, Validation, Manufacturing, and QA.,Follow all relevant GxP regulations, guidelines, and company policies.,Follow Good Documentation Practices and Data Integrity requirements.
Currently enrolled in an undergraduate or graduate program in Engineering, Computer Science, or other technical degrees.,Strong fundamental scientific and engineering skills.,Familiarity with at least one programming language.,Curiosity about process, automation, and MES systems.,Strong problem-solving skills, willingness to learn, and ability to work in a team.,Ability to work effectively in a team-oriented environment.,Demonstrated aptitude or ability to learn to gain a strong understanding of GxP regulations.
Undergraduate or Graduate Co-op program (Engineering, Computer Science, or Technical degree)
Full time (July 13th-Dec 11th 2026)
Must already hold work authorization in US and be able to maintain that status without future sponsorship.,Employment is contingent upon ability to access export-controlled information in accordance with U.S. law.,Only individuals who qualify as U.S. persons (citizens, permanent residents, asylees, or refugees) are eligible due to export control regulations.
Moderna is a biotechnology company pioneering a new class of medicines made of messenger RNA (mRNA). The company's platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and autoimmune diseases.
BerryMap uses cookies to provide essential features, analyze usage, and improve your experience. You can customize your preferences below.